What is the clinical effectiveness and cost-effectiveness of nebulised saline in patients with chronic obstructive pulmonary disease (MucAct COPD Trial)?

Project Details

StatusActive
Effective start/end date1/02/2030/06/24

Funding

  • Other: £1,546,689.00